250 related articles for article (PubMed ID: 22938452)
21. Diagnostic roles of MUC1 and GLUT1 in differentiating thymic carcinoma from type B3 thymoma.
Du MJ; Shen Q; Yin H; Rao Q; Zhou MX
Pathol Res Pract; 2016 Nov; 212(11):1048-1051. PubMed ID: 27688088
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
Nonaka D; Henley JD; Chiriboga L; Yee H
Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
[TBL] [Abstract][Full Text] [Related]
23. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.
Hayashi A; Fumon T; Miki Y; Sato H; Yoshino T; Takahashi K
J Clin Exp Hematop; 2013; 53(1):9-19. PubMed ID: 23801129
[TBL] [Abstract][Full Text] [Related]
24. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P
Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
[TBL] [Abstract][Full Text] [Related]
25. Thymic epithelial tumors: prognostic determinants among clinical, histopathologic, and computed tomography findings.
Moon JW; Lee KS; Shin MH; Kim S; Woo SY; Lee G; Han J; Shim YM; Choi YS
Ann Thorac Surg; 2015 Feb; 99(2):462-70. PubMed ID: 25534526
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-1 receptor expression in thymic malignancies.
Girard N; Teruya-Feldstein J; Payabyab EC; Riely GJ; Rusch VW; Kris MG; Zakowski MF
J Thorac Oncol; 2010 Sep; 5(9):1439-46. PubMed ID: 20736806
[TBL] [Abstract][Full Text] [Related]
27. Expression of pRb and p16INK4 in human thymic epithelial tumors in relation to the presence of human polyomavirus 7.
Keijzers M; Rensspiess D; Pujari S; Abdul-Hamid MA; Hochstenbag M; Dingemans AM; Kurz AK; Haugg A; Maessen JG; De Baets MH; Zur Hausen A
Diagn Pathol; 2015 Nov; 10():201. PubMed ID: 26537237
[TBL] [Abstract][Full Text] [Related]
28. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of tumour size in completely resected thymic epithelial tumours.
Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
Eur J Cardiothorac Surg; 2016 Dec; 50(6):1068-1074. PubMed ID: 27999073
[TBL] [Abstract][Full Text] [Related]
30. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors.
Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G
Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724
[TBL] [Abstract][Full Text] [Related]
31. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.
Omasa M; Date H; Sozu T; Sato T; Nagai K; Yokoi K; Okamoto T; Ikeda N; Tanaka F; Maniwa Y;
Cancer; 2015 Apr; 121(7):1008-16. PubMed ID: 25565590
[TBL] [Abstract][Full Text] [Related]
32. Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems.
Ma Y; Li Q; Cui W; Miao N; Liu X; Zhang W; Zhang C; Wang J
Diagn Pathol; 2012 Sep; 7():120. PubMed ID: 22974165
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors.
Meurgey A; Girard N; Merveilleux du Vignaux C; Maury JM; Tronc F; Thivolet-Bejui F; Chalabreysse L
J Thorac Oncol; 2017 Oct; 12(10):1571-1581. PubMed ID: 28694035
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathological character and long-term results of thymic epithelial tumor categorized by WHO classification].
Nakamura H; Taniguchi Y; Ohgi S
Kyobu Geka; 2002 Oct; 55(11):931-5. PubMed ID: 12391688
[TBL] [Abstract][Full Text] [Related]
35. Correlation between the Expression of PD-L1 and Clinicopathological Features in Patients with Thymic Epithelial Tumors.
Chen Y; Zhang Y; Chai X; Gao J; Chen G; Zhang W; Zhang Y
Biomed Res Int; 2018; 2018():5830547. PubMed ID: 29850538
[TBL] [Abstract][Full Text] [Related]
36. Expression of cathepsins V and S in thymic epithelial tumors.
Kiuchi S; Tomaru U; Ishizu A; Imagawa M; Kiuchi T; Iwasaki S; Suzuki A; Otsuka N; Deguchi T; Shimizu T; Marukawa K; Matsuno Y; Kasahara M
Hum Pathol; 2017 Feb; 60():66-74. PubMed ID: 27771373
[TBL] [Abstract][Full Text] [Related]
37. Expression of cancer testis antigens in thymic epithelial tumors.
Sakane T; Murase T; Okuda K; Masaki A; Nakanishi R; Inagaki H
Pathol Int; 2021 Jul; 71(7):471-479. PubMed ID: 33902161
[TBL] [Abstract][Full Text] [Related]
38. Proliferative activity and apoptosis in thymic epithelial neoplasms.
Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
[TBL] [Abstract][Full Text] [Related]
39. Imatinib mesylate in thymic epithelial malignancies.
Palmieri G; Marino M; Buonerba C; Federico P; Conti S; Milella M; Petillo L; Evoli A; Lalle M; Ceribelli A; Merola G; Matano E; Sioletic S; De Placido S; Di Lorenzo G; Damiano V
Cancer Chemother Pharmacol; 2012 Feb; 69(2):309-15. PubMed ID: 21710245
[TBL] [Abstract][Full Text] [Related]
40. Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.
Thomas A; Chen Y; Berman A; Schrump DS; Giaccone G; Pastan I; Venzon DJ; Liewehr DJ; Steinberg SM; Miettinen M; Hassan R; Rajan A
Lung Cancer; 2016 Nov; 101():104-110. PubMed ID: 27794397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]